title: TLR2 mediates the innate response of retinal Muller glia to Staphylococcus aureus.
abstract: Muller cells, the principal glia of the retina, play several key roles in normal and various retinal diseases. To date, their direct involvement in retinal innate defense against bacterial pathogens has not been investigated. In this article, we show that Muller cells express TLR2, a key sensor implicated in recognizing Gram-positive bacteria. We found that intravitreal injection of TLR2 agonist Pam3Cys and Staphylococcus aureus activated Muller glia in C57BL/6 mouse retina. Similarly, Pam3Cys or S. aureus elicited the expression of TLR2 and activated the NF-κB and p38 MAPK signaling cascade. Concomitant with the activation of signaling pathways, transcriptional expression and secretion of various proinflammatory cytokines (IL-6, TNF-α, and IL-1β), chemokines (IL-8), and antimicrobial peptide (LL-37) were also induced in Muller glia. Importantly, the culture media derived from TLR2-activated Muller glia exhibited robust bactericidal activity against S. aureus. Furthermore, use of neutralizing Ab, small interfering RNA, and pharmacological inhibitors revealed that Muller glial innate response to S. aureus is mediated via the TLR2-NF-κB axis. Collectively, this study for the first time, to our knowledge, establishes that the retinal Muller glia senses pathogens via TLR2 and contributes directly to retinal innate defense via production of inflammatory mediators and antimicrobial peptides.
authors: Department of Ophthalmology, Kresge Eye Institute, Wayne State University, Detroit, MI 48201, USA.
authors: Nazeem
authors: N
authors: Shamsuddin
authors: Ashok
authors: A
authors: Kumar
references: Arch Ophthalmol. 1991 Aug;109(8):1085-9
references: 1867549
references: Virology. 1997 Aug 4;234(2):309-16
references: 9268163
references: Infect Immun. 2006 Sep;74(9):5325-32
references: 16926427
references: Trends Mol Med. 2010 Apr;16(4):193-202
references: 20303826
references: Invest Ophthalmol Vis Sci. 2002 Mar;43(3):864-9
references: 11867609
references: Curr Eye Res. 2006 Nov;31(11):955-65
references: 17114121
references: Infect Immun. 1999 Nov;67(11):6084-9
references: 10531270
references: Invest Ophthalmol Vis Sci. 2009 Aug;50(8):3783-93
references: 19264886
references: Ocul Immunol Inflamm. 2010 Aug;18(4):237-43
references: 20662654
references: Invest Ophthalmol Vis Sci. 2009 Apr;50(4):1739-45
references: 19098321
references: Prog Retin Eye Res. 2009 Jul;28(4):249-62
references: 19465144
references: Rev Infect Dis. 1985 Nov-Dec;7 Suppl 4:S594-604
references: 3909316
references: J Allergy Clin Immunol. 2009 Sep;124(3 Suppl 2):R13-8
references: 19720207
references: Cell Mol Life Sci. 2003 Apr;60(4):711-20
references: 12785718
references: Invest Ophthalmol Vis Sci. 2010 Mar;51(3):1683-90
references: 19892866
references: Cell Tissue Res. 1991 Jun;264(3):437-51
references: 1868519
references: Prog Retin Eye Res. 2009 Sep;28(5):348-68
references: 19560552
references: Infect Immun. 1997 Apr;65(4):1550-6
references: 9119503
references: Prog Retin Eye Res. 2006 Jul;25(4):397-424
references: 16839797
references: Invest Ophthalmol Vis Sci. 2005 Jul;46(7):2479-86
references: 15980239
references: Microb Pathog. 2008 May;44(5):426-34
references: 18191935
references: Microbes Infect. 2006 Feb;8(2):380-9
references: 16242370
references: J Neurochem. 2004 Feb;88(3):746-58
references: 14720224
references: J Immunol. 2000 Nov 15;165(10):5392-6
references: 11067888
references: Eur J Immunol. 2010 Mar;40(3):624-7
references: 20201016
references: J Leukoc Biol. 2004 Jan;75(1):39-48
references: 12960280
references: Ophthalmology. 1989 Dec;96(12):1722-6
references: 2622617
references: Histol Histopathol. 2003 Oct;18(4):1205-18
references: 12973689
references: Curr Eye Res. 2006 Sep;31(9):693-702
references: 16966141
references: Br J Ophthalmol. 2010 Jan;94(1):111-4
references: 19692359
references: Nat Rev Immunol. 2003 Nov;3(11):879-89
references: 14668804
references: Invest Ophthalmol Vis Sci. 2004 Oct;45(10):3513-22
references: 15452057
references: Science. 1999 Oct 15;286(5439):420-1
references: 10577203
references: Infect Immun. 1999 Jul;67(7):3348-56
references: 10377112
references: Clin Microbiol Rev. 2005 Jul;18(3):521-40
references: 16020688
references: PLoS One. 2010 Feb 26;5(2):e9351
references: 20195469
references: J Infect Dis. 2010 Jan 15;201(2):255-63
references: 19995266
references: J Neurosci Res. 1997 Aug 1;49(3):268-80
references: 9260738
references: Br J Ophthalmol. 2005 Jul;89(7):904-10
references: 15965176
references: Infect Immun. 2008 Apr;76(4):1781-90
references: 18227158
references: FEBS Lett. 1995 Jul 10;368(1):173-6
references: 7615076
references: Ophthalmology. 1998 Dec;105(12):2171-7
references: 9855143
references: Chem Immunol Allergy. 2007;92:266-275
references: 17264502
references: Clin Infect Dis. 2009 Dec 1;49(11):1749-55
references: 19857164
references: J Immunol. 2010 Mar 1;184(5):2355-68
references: 20118281
references: Invest Ophthalmol Vis Sci. 2007 Dec;48(12):5616-23
references: 18055811
references: Invest Ophthalmol Vis Sci. 1995 Aug;36(9):1828-36
references: 7635657
references: Ophthalmologica. 2001 Sep-Oct;215(5):321-36
references: 11528258
references: Microsc Res Tech. 2000 Sep 1;50(5):384-93
references: 10941174
references: Exp Eye Res. 2010 Jun;90(6):679-87
references: 20346359
references: Prog Retin Eye Res. 2007 Mar;26(2):189-203
references: 17236804
references: Diabetologia. 2010 Dec;53(12):2656-66
references: 20835858
references: Neurochem Res. 2008 Aug;33(8):1466-74
references: 18273703
references: Am J Ophthalmol. 2010 Sep;150(3):295-304.e1
references: 20630493
references: Semin Immunol. 2009 Aug;21(4):199-207
references: 19539499
references: Invest Ophthalmol Vis Sci. 2008 Apr;49(4):1518-24
references: 18385071